BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38463621)

  • 1. Promoting advanced medical services in the framework of 3PM-a proof-of-concept by the "Centro" Region of Portugal.
    Regateiro FJ; Silva H; Lemos MC; Moura G; Torres P; Pereira AD; Dias L; Ferreira PL; Amaral S; Santos MAS
    EPMA J; 2024 Mar; 15(1):135-148. PubMed ID: 38463621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social determinants of health and their relation to suboptimal health status in the context of 3PM: a latent profile analysis.
    Tong LK; Li YY; Liu YB; Zheng MR; Fu GL; Au ML
    EPMA J; 2024 Jun; 15(2):221-232. PubMed ID: 38841621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.
    Bajinka O; Ouedraogo SY; Golubnitschaja O; Li N; Zhan X
    EPMA J; 2024 Jun; 15(2):289-319. PubMed ID: 38841622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative omics approaches and machine-learning strategies.
    Yang F; Wendusubilige ; Kong J; Zong Y; Wang M; Jing C; Ma Z; Li W; Cao R; Jing S; Gao J; Li W; Wang J
    EPMA J; 2023 Sep; 14(3):417-442. PubMed ID: 37605652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach.
    Yang J; Ouedraogo SY; Wang J; Li Z; Feng X; Ye Z; Zheng S; Li N; Zhan X
    EPMA J; 2024 Mar; 15(1):67-97. PubMed ID: 38463626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conceptualised psycho-medical footprint for health status outcomes and the potential impacts for early detection and prevention of chronic diseases in the context of 3P medicine.
    Afrifa-Yamoah E; Adua E; Anto EO; Peprah-Yamoah E; Opoku-Yamoah V; Aboagye E; Hashmi R
    EPMA J; 2023 Dec; 14(4):585-599. PubMed ID: 38094584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mediating effect of perceived stress on the relationship between big five personality traits and suboptimal health status in Chinese population: a nationwide survey in the framework of predictive, preventive, and personalized medicine.
    Guan Q; Dong H; Zhang Z; Guo Z; Lin Z; Niu H; Wu Y; Hou H
    EPMA J; 2024 Mar; 15(1):25-38. PubMed ID: 38463623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive multi-omics analysis of the m7G in pan-cancer from the perspective of predictive, preventive, and personalized medicine.
    Huang X; Chen Z; Xiang X; Liu Y; Long X; Li K; Qin M; Long C; Mo X; Tang W; Liu J
    EPMA J; 2022 Dec; 13(4):671-697. PubMed ID: 36505892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression-3PM pathways.
    Kubatka P; Mazurakova A; Samec M; Koklesova L; Zhai K; Al-Ishaq R; Kajo K; Biringer K; Vybohova D; Brockmueller A; Pec M; Shakibaei M; Giordano FA; Büsselberg D; Golubnitschaja O
    EPMA J; 2021 Dec; 12(4):559-587. PubMed ID: 34950252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of pretreatment red blood cell distribution width in primary diffuse large B-cell lymphoma of the central nervous system for 3P medical approaches in multiple cohorts.
    Li D; Li S; Xia Z; Cao J; Zhang J; Chen B; Zhang X; Zhu W; Fang J; Liu Q; Hua W
    EPMA J; 2022 Sep; 13(3):499-517. PubMed ID: 36061828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management.
    Liskova A; Samec M; Koklesova L; Giordano FA; Kubatka P; Golubnitschaja O
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32854390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
    Golubnitschaja O; Polivka J; Potuznik P; Pesta M; Stetkarova I; Mazurakova A; Lackova L; Kubatka P; Kropp M; Thumann G; Erb C; Fröhlich H; Wang W; Baban B; Kapalla M; Shapira N; Richter K; Karabatsiakis A; Smokovski I; Schmeel LC; Gkika E; Paul F; Parini P; Polivka J
    EPMA J; 2024 Mar; 15(1):1-23. PubMed ID: 38463624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of IgG N-glycomics with prevalent and incident type 2 diabetes mellitus from the paradigm of predictive, preventive, and personalized medicine standpoint.
    Meng X; Wang F; Gao X; Wang B; Xu X; Wang Y; Wang W; Zeng Q
    EPMA J; 2023 Mar; 14(1):1-20. PubMed ID: 36866157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and cost-effectiveness of different breast cancer surgery procedures: a Markov decision tree-based approach in the framework of Predictive, Preventive, and Personalized Medicine.
    Shi HY; Li CH; Chen YC; Chiu CC; Lee HH; Hou MF
    EPMA J; 2023 Sep; 14(3):457-475. PubMed ID: 37605647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context.
    Skladany L; Koller T; Adamcova Selcanova S; Vnencakova J; Jancekova D; Durajova V; Laffers L; Svac J; Janickova K; Palkovič M; Kohout P; Golubnitschaja O
    EPMA J; 2021 Mar; 12(1):1-14. PubMed ID: 33680218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oculomics for sarcopenia prediction: a machine learning approach toward predictive, preventive, and personalized medicine.
    Kim BR; Yoo TK; Kim HK; Ryu IH; Kim JK; Lee IS; Kim JS; Shin DH; Kim YS; Kim BT
    EPMA J; 2022 Sep; 13(3):367-382. PubMed ID: 36061832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital biomarkers: 3PM approach revolutionizing chronic disease management - EPMA 2024 position.
    Smokovski I; Steinle N; Behnke A; Bhaskar SMM; Grech G; Richter K; Niklewski G; Birkenbihl C; Parini P; Andrews RJ; Bauchner H; Golubnitschaja O
    EPMA J; 2024 Jun; 15(2):149-162. PubMed ID: 38841615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.